Clinical Trial Update: Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating carnitine consumption and augmentation in pulmonary arterial hypertension has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2025-02-13